Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats

Journal of Pharmacology and Experimental Therapeutics

Volumn 300, Issue 2, 2002, Pages 588-596

  Powell, Kelly J ^a   Abul Husn, Noura S ^a   Jhamandas, Asha ^a   Olmstead, Mary C ^a   Beninger, Richard J ^a   Jhamandas, Khem ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MORPHINE; NALTREXONE; OPIATE ANTAGONIST;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENTIATION; DRUG TOLERANCE; LONG TERM CARE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD;

ANALGESICS, OPIOID; ANIMALS; CONDITIONING, OPERANT; DRUG TOLERANCE; INJECTIONS, INTRAPERITONEAL; INJECTIONS, SPINAL; MALE; MICE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; REWARD;

EID: 0036156508     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.300.2.588     Document Type: Article

References (38)

1. Ultra-low doses of mu and delta opioid receptor antagonists augment spinal morphine antinociception and inhibit the development of tolerance
2. Inhibitor of cyclic AMP-dependent protein kinase blocks opioid-induced prolongation of the action potential of mouse sensory ganglion neurons in dissociated cell cultures
3. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons
4. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside
5. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment
6. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions
7. GM1 ganglioside-induced modulation of opioid receptor-mediated functions
8. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability
9. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia
10. Analgesia and the neural substrate of reward
11. Analgesia and abuse potential: An accidental association or a common substrate?
12. Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties
13. Heterodimerization of mu and delta opioid receptors: A role in opiate synergy
14. Role of adenosine in the spinal antinociceptive and morphine modulatory actions of neuropeptide FF analogs
15. Functional couplings of the delta- and the kappa-opioid receptors with the G-protein-activated K+ channel
16. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model
17. Pain modulating and reward systems: A single brain mechanism?
18. Analgesia and autonomic function following intrathecal administration of morphine and norepinephrine to the rat
19. Mechanisms of hyperalgesia and morphine tolerance: A current view of their possible interactions
20. A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia
21. Opiate activation of potassium conductance inhibits calcium action potentials in rat locus coeruleus neurones
22. The development of a conditioned place preference to morphine: Effects of microinjections into various CNS sites
23. Incomplete cross tolerance and multiple mu opioid peptide receptors
24. Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance
25. Direct demonstration of the activation of UDP-N-acetylgalactosamine: [GM3]N-acetylgalactosaminyltransferase by cyclic AMP
26. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture
27. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice
28. The stimulatory effects of opioids and their possible role in the development of tolerance
29. The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells
30. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release
31. An opiate-receptor gene family reunion
32. Opiate reward: Sites and substrates
33. Interaction of the delta-opioid receptor with GM1 ganglioside: Conversion from inhibitory to excitatory mode
34. The role of GM1 ganglioside in regulating excitatory opioid effects
35. Sites of action of opiates in production of analgesia
36. Chronic catheterization of spinal subarachnoid space
37. Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat
38. Involvement of arcuate nucleus of hypothalamus in the descending pathway from nucleus accumbens to periaqueductal grey subserving an antinociceptive effect